Advisor/Sr. Advisor Bioconjugation Process Development at Eli Lilly and Company

Indianapolis, Indiana, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, PharmaceuticalsIndustries

Requirements

PhD in synthetic organic chemistry, biochemistry, chemical biology, or related field OR MS in related field with 5+ years of relevant industrial experience
Experience with synthetic organic chemistry and bioconjugation to produce ADCs and similar modalities
Additional Skills/Preferences
Postdoctoral experience in a field related to bioconjugation
Experience with small molecule organic synthesis
Knowledge of small molecule organic synthesis

Responsibilities

Establish a productive laboratory program by personally conducting and managing internal and external research plans, collaborate with teammates to analyze results, form conclusions, propose logical next steps, and report findings to a larger team
Thrive at the interface between disciplines and departments to quickly move from one scientific challenge to another while navigating ambiguity
Perform fundamental and detailed studies of each process step for bioconjugation development
Propose and test new methods to achieve bioconjugation and bioconjugate development; collaborate and share findings with discovery scientists
Embrace and celebrate diversity by using a relevant and unique background and set of experiences to provide new ideas to deliver innovative solutions
Demonstrate strong communication (oral and written), organizational, and leadership skills
Bring new and useful concepts, methods, and ideas for how research can be improved and share these to make the group better
Engage externally through conference attendance, presentations, and publications
Identify, partner, and develop process innovations from the outside to complement existing capabilities and areas of focus and incorporate these across the portfolio
Demonstrate learning agility across modalities (e.g., small molecule, peptide, and oligonucleotide)
Help drive and develop the commercial manufacturing strategy and collaborate with manufacturing partners to deliver robust processes suitable for large-scale manufacturing

Skills

Bioconjugation

Process Development

Synthetic Organic Chemistry

ADCs

Antibody-Drug Conjugates

APCs

ARCs

AOCs

Bioprocess Engineering

Scale-up

Manufacturing

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free